This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Savard, J. Articles by Morin, C. M. Search for Related Content PubMed PubMed Citation Articles by Savard, J. Articles by Morin, C. M.

Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part II: Immunologic Effects

From the Laval University Cancer Research Center; and School of Psychology, Université Laval, Québec, Québec, Canada

Address reprint requests to Josée Savard, PhD, Laval University Cancer Research Center, 11 Côte du Palais, Québec, Québec, Canada, G1R 2J6; e-mail: josee.savard{at}psy.ulaval.ca

PURPOSE: Cross-sectional studies suggest that clinical insomnia is associated with immune downregulation. However, there is a definite need for experimental studies on this question. The goal of this randomized controlled study was to assess the effect of an 8-week cognitive-behavioral therapy (CBT) for chronic insomnia on immune functioning of breast cancer survivors. Previous analyses of this study showed that CBT was associated with improved sleep and quality of life, and reduced psychological distress.

PATIENTS AND METHODS: Fifty-seven women with chronic insomnia secondary to breast cancer were randomly assigned to CBT (n = 27) or to a waiting-list control condition (WLC; n = 30). Peripheral-blood samples were taken at baseline and post-treatment (and postwaiting for WLC patients), as well as at 3-, 6-, and 12-month follow-up for immune measures, including enumeration of blood cell counts (ie, WBCs, monocytes, lymphocytes, CD3⁺, CD4⁺, CD8⁺, and CD16⁺/CD56⁺) and cytokine production (ie, interleukin-1-beta [IL-1ß] and interferon gamma [IFN-]).

RESULTS: Patients treated with CBT had higher secretion of IFN- and lower increase of lymphocytes at post-treatment compared with control patients. Pooled data from both treated groups indicated significantly increased levels of IFN- and IL-1ß from pre- to post-treatment. In addition, significant changes in WBCs, lymphocytes, and IFN- were found at follow-up compared with post-treatment.

CONCLUSION: This study provides some support to the hypothesis of a causal relationship between clinical insomnia and immune functioning. Future studies are needed to investigate the clinical impact of such immune alterations.

Supported in part by an operating grant (MT-14039) and salary support from the Canadian Institutes of Health Research.

Presented in part at the 2nd Annual Conference of the American Psychosocial Oncology Society, Phoenix, AZ, January 2005.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer J. Clin. Oncol., February 20, 2008; 26(6): 971 - 982. [Abstract] [Full Text] [PDF]

				J. Savard, S. Simard, H. Ivers, and C. M. Morin Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological Effects J. Clin. Oncol., September 1, 2005; 23(25): 6083 - 6096. [Abstract] [Full Text] [PDF]